Atara Biotherapeutics, Inc. (ATRA)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 0.5682 |
| 開市 | 0.5681 |
| 買盤 | 0.5626 x 800 |
| 賣出價 | 0.5708 x 400 |
| 今日波幅 | 0.5500 - 0.5887 |
| 52 週波幅 | 0.1990 - 2.5350 |
| 成交量 | |
| 平均成交量 | 1,533,614 |
| 市值 | 67.541M |
| Beta 值 (5 年，每月) | 0.70 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.1300 |
| 業績公佈日 | 2024年8月06日 - 2024年8月12日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 4.17 |
ZacksBiogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Biogen's (BIIB) acquisition of private biotech, HI-Bio, is set to expand its rare disease pipeline by adding the latter's lead asset, felzartamab.
ZacksGSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
GSK's depemokimab has the potential to become the first ultra-long-acting biologic for severe asthma with a six-month dosing schedule
ZacksAtara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates
Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of 37.84% and 1.32%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
